Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

LEO Pharma announces positive results from phase 2b clinical study for Tralokinumab in Atopic Dermat

pharmaasiaMarch 16, 2017

Tag: LEO Pharma , eczema

PharmaSources Customer Service